[Antidiabetics in type 2 diabetes - Do we manage new knowledge properly?]
Tidsskr Nor Laegeforen
.
2017 Aug 21;137(14-15).
doi: 10.4045/tidsskr.17.0002.
Print 2017 Aug 22.
[Article in Norwegian]
Authors
Gard Frodahl Tveitevåg Svingen
,
Kjetil Halvorsen Løland
PMID:
28828781
DOI:
10.4045/tidsskr.17.0002
No abstract available
MeSH terms
Diabetes Mellitus, Type 2 / drug therapy*
Evidence-Based Medicine*
Humans
Hypoglycemic Agents / therapeutic use*
Knowledge Management
Practice Guidelines as Topic
Substances
Hypoglycemic Agents